Multiple Endocrine Neoplasia: Clinical Trials

10 trials for Multiple Endocrine Neoplasia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 1 unknown. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Completed 9, Unknown 1

Follow Multiple Endocrine Neoplasia: new trials by email Literature Review of Multiple Endocrine Neoplasia trials Research Report on Multiple Endocrine Neoplasia

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment
Alpelisib, Fulvestrant - Advanced Breast Cancer
Phase 4CompletedNovartis Pharmaceuticals402022-08-092026-07-09
GRK4 Polymorphisms Blood Pressure Response to Candesartan
Candesartan - Essential Hypertension
Phase 4UnknownThird Military Medical University5002013-07-012014-11-18
Effects of Growth Hormone Administration on Muscle Strength and Body Composition in Men Over 50 Years Old
growth hormone - Healthy
Phase 4CompletedUniversidade Federal do Rio de Janeiro132012-01-012014-09-03
How Much Vitamin D is Required to be Protective Against Deficiency During the Winter Months?
Vitamin D, placebo - Vitamin D Deficiency
Phase 4CompletedMcGill University772011-10-012014-09-05
Effects of Diet-induced Weight Loss in Obese Men
Optifast, Conventional diet counseling - Sexual Dysfunction, Endothelial Dysfunction
Phase 4CompletedChangi General Hospital702010-12-012015-07-29
Comparing Effects of Diet, With or Without Exercise, on Sexual, Urinary and Endothelial Function, Inflammatory Profile and Quality of Life in Obese Men
weight loss counselling - Sexual Dysfunction, Endothelial Dysfunction
Phase 4CompletedChangi General Hospital902010-07-012015-07-29
Effects of Lifestyle-modification Induced Weight Loss on Sexual and Urinary Function, and Quality of Life in Obese Men
Exercise and diet - Sexual Dysfunction, Endothelial Dysfunction
Phase 4CompletedChangi General Hospital702010-07-012015-07-29
Comparison of Two Antimicrobial Therapy Duration for Spondylodiscitis
antibiotic - Vertebral Osteomyelitis
Phase 4CompletedAssistance Publique - Hôpitaux de Paris3512006-11-012013-05-06
Treatment of Zollinger-Ellison Syndrome With Prevacid
Lansoprazole (Prevacid) - Zollinger-Ellison Syndrome, Multiple Endocrine Neoplasia
Phase 4CompletedCharles Mel Wilcox, MD722003-03-012012-10-30
The Role of 5-alpha Reductase in Mediating Testosterone Actions
Testosterone Enanthate, Dutasteride - Healthy
Phase 4CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1842002-11-012010-05-13

Narrower conditions

Multiple Endocrine Neoplasia Type 1 (9)  ·  Inflammation (4)  ·  Obesity (3)  ·  Sexual Dysfunction, Physiological (3)  ·  Discitis (1)  ·  Essential Hypertension (1)  ·  Vitamin D Deficiency (1)  ·  Zollinger-Ellison Syndrome (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (10)  ·  Endocrine Gland Neoplasms (10)  ·  Endocrine System Diseases (10)  ·  Genetic Diseases, Inborn (10)  ·  Neoplasms (10)  ·  Neoplasms by Site (10)  ·  Neoplasms, Multiple Primary (10)  ·  Neoplastic Syndromes, Hereditary (10)  ·  Nutrition Disorders (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Body Weight (3)  ·  Genital Diseases (3)

Interventions

Alpelisib (1)  ·  Anti-Bacterial Agents (1)  ·  Diet (1)  ·  Dutasteride (1)  ·  Exercise (1)  ·  Fulvestrant (1)  ·  Growth Hormone (1)  ·  Lansoprazole (1)  ·  Nutrition Assessment (1)  ·  Vitamin D (1)  ·  candesartan (1)  ·  testosterone enanthate (1)

Sponsors

Changi General Hospital (3)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Charles Mel Wilcox, MD (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  McGill University (1)  ·  Novartis Pharmaceuticals (1)  ·  Third Military Medical University (1)  ·  Universidade Federal do Rio de Janeiro (1)

Countries

Singapore (3)  ·  Brazil (1)  ·  Canada (1)  ·  China (1)  ·  France (1)  ·  India (1)  ·  United States (1)

Top investigators

C. Mel Wilcox, M.D. (1)  ·  Hope A Weiler, PhD, RD (1)  ·  Joan J Khoo, MRCP (1)  ·  Joan Khoo, MBBS,MRCP (1)  ·  Joan Khoo, MRCP (1)  ·  Louis Bernard, PU-PH (1)  ·  Shalender Bhasin, MD (1)  ·  Zeng Chunyu, Doctor (1)

Results publications

PMID 15645403, PMID 17767471, PMID 18507843, PMID 19581810, PMID 21073392, PMID 21193359, PMID 22396515, PMID 23635309, PMID 24382963, PMID 25468170, PMID 25984880, PMID 26201019, PMID 26438497, PMID 26871769, PMID 29280355

NIH funding

R01HD043348 (1)